Table 7 Mortality rate in the ceftaroline and control groups
Study | Mortality rate, n (%) | |
|---|---|---|
Ceftaroline group | Control group | |
Jandourek et al, 2014 | – | – |
File et al, 2011 | 6/298 (2.0) | 6/308 (1.9) |
Low et al, 2011 | 9/315 (2.9) | 6/307 (2.0) |
Shorr et al, 2013 | – | 1/70 (1.4) |
File et al, 2010 | 15/613 (2.4) | 12/615 (2.0) |
Zhong et al, 2015 | 3/381 (0.8) | 4/383 (1.0) |
Arshad et al, 2016 28-day mortality | 4/40 (10.0)a | 16/109 (14.7)a |
Eckburg et al, 2012 | – | – |
Ramani et al, 2014 | 8/398 (2.0)b | – |
Casapao et al, 2014 | 13/92 (14.1)b | – |
Vasquez et al, 2015 | 1/21 (4.8) | – |
Guervil et al, 2015 | 8/396 (2.0)b | – |
Kaye et al, 2015 | 5/40 (12.5) | – |
Udeani et al, 2014 | 15/528 (2.8) | – |